Intrinsic value of Integra LifeSciences Holdings Corporation (IART)

[per Chepakovich valuation model]

other valuations of IART

[per Chepakovich valuation model]  See other valuations of IART stock

Previous Close$67.15
Intrinsic Value
Upside potential
Previous Close
$67.15

VALUATION INPUT DATA

Revenue, mln $
Initial revenue growth rate (norm.), %
Variable cost ratio, %
Fixed operating expenses, mln $
Production assets / Revenue, %
Working capital / Revenue, %
Interest rate on debt, %
Life of production assets, yrs
Initial discount rate, %
Shares outstanding, mln
Adjusted equity ratio
Adjusted assets / Revenue
Based on fiscal year data as of 2020-12-31 and quarterly data as of 2021-03-31.
NOTE: The bar chart shows historic and forecasted yearly revenue growth rates. Its purpose is to help you in determining what initial revenue rate you want to base your stock valuation on. Please make sure that you are confident in the value you select - for most stocks it is by far the most important parameter in valuation.
  1. Annual
  2. Quarterly YoY
  3. Quarterly QoQ

Annual revenue growth rates, % (past and forecasted)

show cash flow forecast

FINANCIAL STATEMENTS FORECAST and PRESENT VALUE CALCULATION

Fiscal year2020(a)2021202220232024202520262027202820292030203120322033203420352036203720382039204020412042204320442045

INCOME STATEMENT

Revenue growth rate, %-9.6NaN
Revenue, $1372NaN
Variable operating expenses, $mNaN
Fixed operating expenses, $mNaN
Total operating expenses, $m1220NaN
Operating income, $m151NaN
EBITDA, $m295NaN
Interest expense (income), $mNaN
Earnings before tax, $m94NaN
Tax expense, $m-40NaN
Net income, $m134NaN

BALANCE SHEET

Cash and short-term investments, $m470NaN
Total assets, $m3615NaN
Adjusted assets (=assets-cash), $m3145NaN
Average production assets, $m2266NaN
Working capital, $m836NaN
Total debt, $m1521NaN
Total liabilities, $m2100NaN
Total equity, $m1515NaN
Debt-to-equity ratio1.004NaN
Adjusted equity ratio0.368NaN

CASH FLOW

Net income, $m134NaN
Depreciation, amort., depletion, $m144NaN
Funds from operations, $mNaN
Change in working capital, $mNaN
Cash from operations, $m204NaN
Maintenance CAPEX, $mNaN
New CAPEX, $mNaN
Total CAPEX, $m-35NaN
Free cash flow, $m239NaN
Issuance/(repurchase) of shares, $mNaN
Retained Cash Flow, $mNaN
Pot'l extraordinary dividend, $m836
Cash available for distribution, $mNaN
Discount rate, %NaN
PV of cash for distribution, $mNaN
Current shareholders' claim on cash, %NaN